Feasibility of large-scale population testing for SARS-CoV-2 detection by self-testing at home

Iruzubieta, Paula; Fernández-Lanas, Tatiana; Rasines, Laura; Cayon, Lorena; Álvarez-Cancelo, Ana; Santos-Laso, Alvaro; García-Blanco, Agustín; Curiel-Olmo, Soraya; Cabezas, Joaquín; Wallmann, Reinhard; Fábrega, Emilio; Martínez-Taboada, Víctor M.; Hernández, José L.; López-Hoyos, Marcos; Lazarus, Jeffrey V.; Crespo, Javier

The simplicity and low cost of rapid point-of-care tests greatly facilitate large-scale population testing, which can contribute to controlling the spread of the COVID-19 virus. We evaluated the applicability of a self-testing strategy for SARS-CoV2 in a population-based, cross-sectional study in Cantabria, Spain, between April and May 2020. For the self-testing strategy, participants received the necessary material for the self-collection of blood and performance of a rapid antibody test using lateral flow immunoassay at home without the supervision of healthcare personnel. A total of 1,022 participants were enrolled. Most participants correctly performed the COVID-19 self-test the first time (91.3% [95% CI 89.4–92.9]). Only a minority of the participants (0.7%) needed the help of healthcare personnel, while 6.9% required a second kit delivery, for a total valid test result in 96.9% of the participants. Incorrect use of the self-test was not associated with the educational level, age over 65, or housing area. Prevalence of IgG antibodies against SARS-CoV2 for subjects with a valid rapid test result was 3.1% (95% CI 2.2–4.4), similar to the seroprevalence result obtained using a conventional approach carried out by healthcare professionals. In conclusion, COVID-19 self-testing should be considered as a screening tool.